Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4701–4750 of 18416
Mr. Peyovich will succeed Mr. Nielsen as the Company's Chief Executive Officer following the Retirement Date.
Effective June 14, 2024, Kevin Paprzycki was separated as Chief Financial Officer and Treasurer of the Company.
Richard W. Sunderland, Jr., the Company’s current Executive Vice President, Chief Financial Officer, is expected to continue to serve until ninety (90) days after his successor commences employment with the Company
the employment of Chandra Holt as the Division Chief Executive Officer of Bed Bath & Beyond and co-principal executive officer ceased, effective as of June 14, 2024
appointed Mr. Mark King, age 64, as Chief Executive Officer of the Company and as a member of the Board.
On June 13, 2024, Mark Harris informed the Company that he is resigning from the position of Chief Financial Officer and leaving the Company, effective August 16, 2024.
On June 12, 2024, CytomX Therapeutics, Inc. (the “Company”) appointed Chris Ogden to serve as the Company’s Chief Financial Officer effective June 15, 2024 (the “Effective Date”).
On June 14, 2024, the Board of Directors of the Company appointed Chin Sook Lee as Chief Financial Officer of the Company effective as of June 14, 2024.
On June 14, 2024, Michael Chan Meng Chun informed Treasure Global Inc (the “Company”) of his resignation as Chief Financial Officer, which was immediately effective.
In connection with Mr. Read’s appointment, Andrew C. Wiechmann, the Company’s Chief Financial Officer, will no longer be designated as the Company’s principal accounting officer.
entered into an employment agreement with Brad Hauser pursuant to which Mr. Hauser agreed to serve as the Company’s chief executive officer and president
Lisa Brady its President and CEO stepped down effective June 14, 2024.
On June 17, 2024, the Board of Directors (the “Board”) of Oncocyte Corporation (the “Company”) appointed Andrea James to serve as the Company’s Chief Financial Officer, effective June 17, 2024.
resignation of Yinshun He as the Company’s Chief Financial Officer on June 11, 2024.
appointed Kiran Sidhu as the Company’s Interim Chief Financial Officer.
Ms. Albrecht will step down from her role on June 30, 2024 and will serve in an advisory capacity for a period of time to ensure continuity and a successful transition.
On and effective as of June 14, 2024, Velo3D, Inc. (the “Company”) formally appointed Bradley Kreger, a Class III Director of the Company and the Company’s Interim Chief Executive Officer, as the Company’s Chief Executive Officer.
On June 14, 2024, First Interstate BancSystem, Inc. (“First Interstate” or the “Company”) announced the upcoming retirement of President and Chief Executive Officer Kevin P. Riley and has initiated a search for his successor.
On June 14, 2024, STRATTEC SECURITY CORPORATION (the “Company”) issued a press release announcing that the Board of Directors has appointed Jennifer L. Slater as President and Chief Executive Officer effective July 1, 2024.
Repligen has appointed Olivier Loeillot, Repligen’s President and Chief Commercial Officer, to the role of President and Chief Executive Officer, as successor to Tony J. Hunt, who will serve as Executive Chair of the Repligen board of directors (the “Board”), with such transition to be effective September 1, 2024
On June 13, 2024, Chong Chan Teo informed Treasure Global Inc (the “Company”) of his resignation as Chief Executive Officer and a member of the Company’s Board of Directors (“Board”), which was immediately effective.
On June 13, 2024, the Board appointed Carlson Thow as Chief Executive Officer of the Company effective as of June 13, 2024.
In connection with Ms. Fedasz’s appointment as Interim Chief Financial Officer, on June 10, 2024, the Company and Ms. Fedasz entered into a consulting agreement (the “ Fedasz Consulting Agreement ”), pursuant to which Ms. Fedasz will serve as Interim Chief Financial Officer of the Company and will be paid $15,000 per month for up to 80 hours of monthly service to the Company and will provide signatory services for $2,500 per month.
the Board appointed Carlson Thow as Chief Executive Officer of the Company effective as of June 13, 2024.
Chong Chan Teo informed Treasure Global Inc (the “Company”) of his resignation as Chief Executive Officer and a member of the Company’s Board of Directors (“Board”), which was immediately effective.
Effective immediately upon the resignation of Ms. Kaur, the Corporation appointed Mr. Waqas Nakhwa to serve as President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary, and Chairman of the Corporation’s Board of Directors to serve until the next annual meeting of the Corporation or until his respective successor is duly appointed.
On June 7, 2024, the Company received notice of resignation from Ms. Gurneet Kaur from the positions of President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary, and Director of the Corporation.
On June 14, 2024, TriplePoint Venture Growth BDC Corp. (the “Company”) announced Christopher M. Mathieu’s plans to retire as Chief Financial Officer of the Company, effective as of the close of business on August 9, 2024.
On June 14, 2024, TriplePoint Private Venture Credit Inc. (the “Company”) announced Christopher M. Mathieu’s plans to retire as Chief Financial Officer of the Company, effective as of the close of business on August 9, 2024.
Leah Wald ceased serving as chief executive officer (principal executive officer) of the Sponsor
Charles Butler will serve as principal financial officer and principal accounting officer of the Sponsor
Jared Demark will serve as principal executive officer of the Sponsor
John. R. Tyson, the Company’s Executive Vice President and Chief Financial Officer, has been suspended from his duties effective immediately.
Curt Calaway will serve as interim Chief Financial Officer of the Company.
On June 12, 2024, the Board of Directors (the “Board”) of Logitech International S.A. (“Logitech” or “Company”) appointed Meeta Sunderwala, the Company’s Chief Accounting Officer, to the role of Interim Chief Financial Officer (“Interim CFO”) effective immediately.
On June 11, 2024, Voyager Therapeutics, Inc. (the “Company”) and Nathan Jorgensen entered into an employment agreement (the “Jorgensen Agreement”), pursuant to which Dr. Jorgensen agreed to serve as the Chief Financial Officer of the Company, with his employment to commence no later than July 8, 2024
its Board of Directors (the “Board”) has appointed Patrick Kivits as its Chief Executive Officer and a member of the Board effective July 1, 2024
Appointment of Dustin Semach as President and Chief Financial Officer Effective on
the Company also announced that the Board appointed Curran M. Simpson as President and Chief Executive Officer, effective as of July 1, 2024.
On June 7, 2024, Complete Solaria, Inc. (the “Company”) entered into an executive employment agreement (the “Foley Agreement”) with Daniel Foley to serve as Chief Financial Officer, effective July 1, 2024.
On June 10, 2024, the Company appointed Karina M. Fedasz, 51, as Interim Chief Financial Officer of the Company, effective immediately.
On June 8, 2024, Bruce Harmon resigned as Chief Financial Officer of Onconetix, Inc. (the “ Company ”), effective immediately.
On June 10, 2024, the Board of Directors (the “Board”) of ASP Isotopes Inc. (the “Company”) appointed Heather Kiessling as the Chief Financial Officer of the Company, effective as of July 1, 2024
On June 7, 2024, Kevin Kwok notified Glacier Worldwide, Inc. that he was resigning from his position as Chief Financial Officer of Glacier effective June 15, 2024.
The Company separately appointed Charles Krebs as the Company’s Chief Financial Officer, effective June 19, 2024.
on June 6, 2024 Irina Nashtatik resigned as the Company’s Chief Financial Officer.
announcing the appointment, on May 27, 2024, of Joel R. Jung as Interim Chief Financial Officer of the Company in connection with O. James Sterling’s resignation from his position with the Company.
announcing the appointment, on May 27, 2024, of Joel R. Jung as Interim Chief Financial Officer of the Company in connection with O. James Sterling’s resignation from his position with the Company.
Charles Travis Naugle ceased to act as the Chief Executive Officer of the Company on May 22, 2024.
Lei Wang, age 56, was appointed as the Chief Financial Officer and Corporate Secretary of the Company on May 22, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.